GTBP News and Press, GT Biopharma Inc. From 05/03/21

Are You Watching These Former Penny Stocks Right Now? Penny stocks are well-known for their high level of risk and reward. While it’s relatively normal to see stocks under $5 jump sporadically, it’s less frequent to see cheap stocks go on to “graduate” from t...

Hot Biotech Stocks For Your Watch List Today Penny stocks carry plenty of risks, and rightfully so. Considering that we’re talking about stocks under $5, volatility can play a larger role. As you’ll see with this list of penny stocks , however, some go on to rally much...

GT Biopharma (GTBP) announces the appointment of Gregory Berk as the company's chief medical officer.Berk has served as a director on the company's board since November 2020, and will now resign from the role in conjunction with his new appointment.He brings over 30 years of ex...

GT Biopharma Announces the Appointments of Gregory Berk, M.D. to Chief Medical Officer and Jeffrey S. Miller, M.D. to Consulting Chief Scientific Officer PR Newswire BEVERLY HILLS, Calif. , April 26, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clini...

GT Biopharma (NASDAQ: GTBP), a clinical-stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (“NK”) cell engager, TriKE(TM) protein biologic technology platform, has released fourth-quarter and year-end fi...

GT Biopharma (GTBP): Q4 Net loss of $14.9MCash, cash equivalents and investments of $5.3MPress Release For further details see: GT Biopharma reports Q4 results

GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update Posted Significant FDA Clinical Trial Results for GTB-3550 TriKE™ in AML and MDS Patients Established GMP Manufacturing Partnership with Cytovance Initiated Manufacturing of Addition...

iRhythm continues to trade lower as analysts evaluate the impact of Novitas rate update on the company. Meanwhile, the recent FDA approvals have led Truist Securities to upgrade Bristol Myers.iRhythm downgraded at BTIG on uncertain outlookThe revision of Novitas reimbursement rates ...

These Penny Stocks Are Seeing Bullish Sentiment From Analysts Penny stocks remain a hot topic in April. Despite the overall trend in small-cap stocks recently, the broader markets have told a different story. Both the S&P and Dow topped record highs in April thanks to underpinnings ...

GT Biopharma Announces GTB-3550 TriKE™ Monotherapy Rescues and Restores NK Cell Immune Surveillance in Relapsed/Refractory AML and MDS Cancer Patients PR Newswire BEVERLY HILLS, Calif. , April 12, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP)...